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Introduction
Mesenchymal stem cells (MSCs) have been shown to play potential roles in tissue regeneration [1] [2] [3] [4] [5] . Specifically, MSCs are known to promote neovascularization in ischemic myocardium to improve heart function [1] [2] [3] [4] [5] . However, the mechanisms underlying these processes remain unclear. Hence, further studies on the beneficial effects of MSCs on postinjury cardiac muscle repair are quite important.
The most common definition of macrophage activation has applied terms of M1 and M2 macrophages, primarily based on the differential effects of interleukin-4 (IL-4) and interferon gamma (IFN-ɤ) on the macrophage phenotype [6] [7] [8] [9] [10] . While M1 macrophages respond to T helper 1 lymphocytes and generate reactive oxygen species (ROS) and nitric oxide (NO) to destroy and eliminate pathogens and damaged cells, M2 macrophages respond to T helper 2 lymphocytes to mediate humoral immunity and tissue repair [6] [7] [8] [9] [10] [11] [12] . The processes that involve responses of macrophages to differential activation to adapt their phenotypes are called polarization [11, 12] . In vitro, bone-marrow-derived macrophages could be polarized to M1 or M2 macrophages using either IFN-ɤ, or IL-4, respectively [11] [12] [13] . However, macrophages may adapt phenotypes in response to different stimulants, whereas the underlying mechanisms are not completely understood.
Recent studies have indicated an intimate relationship between MSCs and macrophages [14] [15] [16] [17] [18] , and a role of placental growth factor (PLGF) on macrophage polarization [19] [20] [21] [22] . These studies encouraged us to study the relationship between MSCs-derived PLGF and macrophage polarization in our recent published model, in which production and secretion of PLGF by MSCs have been found to be essential for the MSCs-mediated post-injury cardiac muscle repair [23] . Here, we further studied the underlying molecular mechanisms, paying special attention to the interactions among MSCs, macrophages and endothelial cells.
We isolated macrophages from mouse bone-marrow derived cells (BM-MΦ) based on F4/80 expression by flow cytometry. BM-MΦ were treated with different doses of PLGF. Cell number was quantified in an MTT assay. Macrophage polarization was examined based on CD206 expression on macrophages by flow cytometry. PLGF levels in macrophage subpopulations were analyzed by RT-qPCR and ELISA. The role of macrophages on vascularization was evaluated in a collagen gel assay using Human umbilical vein endothelial cells (HUVECs) co-cultured with polarized macrophages. We found that PLGF did not alter macrophage number, but dose-dependently polarized macrophages into a M2 subpopulation. M2 macrophages expressed high levels of PLGF. PLGF-induced M2 macrophages significantly increased tubular structures in the collagen gel assay. Thus, our data suggest that MSCsderived PLGF may induce macrophage polarization into a M2 subpopulation, which in turn releases more PLGF to promote local neovascularization to enhance post-injury cardiac muscle repair.
Materials and Methods

Mouse handling
All mouse experiments were approved by the Institutional Animal Care and Use Committee at Ruijin Hospital, Shanghai Jiaotong University School of Medicine (Animal Welfare Assurance). Male C57BL/6 mice (12-week-old) were used for isolation of bone-marrow cells in the current study.
Isolation and culture of bone-marrow derived mouse macrophages (BM-MΦ)
Isolation of bone-marrow derived mouse macrophages (BM-MΦ) has been described before [24] . 
MTT assay
For assay of cell growth, cells were seeded into 24 well-plate at 10 4 cells per well in the conditioned media and subjected to an MTT Kit (Roche, Indianapolis, IN, USA), according to the instruction of the manufacturer. The MTT assay is a colorimetric assay for assessing viable cell number, since NAD(P) H-dependent cellular oxidoreductase enzymes in viable cells are capable of reducing the tetrazolium dye MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide to its insoluble formazan, which is in purple color and could be quantified by analyzing the absorbance value (OD) of each well at 540 nm. Experiments were performed three times.
Quantitative real-time PCR (RT-qPCR)
RNA was extracted from cultured cells with RNeasy (Qiagen, Hilden, Germany) for cDNA synthesis. Complementary DNA (cDNA) synthesis was performed by reserve transcription. Quantitative PCR (RTqPCR) was performed in duplicates with QuantiTect SYBR Green PCR Kit (Qiagen). All primers were purchased from Qiagen. Quantification used ddCT method. Values of genes were first normalized against β-actin, and then compared to controls.
ELISA
The secreted PLGF was determined by a PLGF ELISA Kit (R&D System, Los Angeles, CA, USA). ELISA was performed according to the instructions of the manufacturer. Briefly, the collected condition media were added to a well coated with PLGF polyclonal antibody, and then immunosorbented by biotinylated monoclonal anti-human PLGF antibody at room temperature for 2 hours. The color development catalyzed by horseradish peroxidase was terminated with 2.5mol/l sulfuric acid and the absorption was measured at 450nm. The protein concentration was determined by comparing the relative absorbance of the samples with the standards.
Collagen gel assay and quantification of vessel formation
HUVECs were obtained from American Type Culture Collection (ATCC, Rockville, MD, USA), and cultured in Dulbecco's Modified Eagle Medium/F12 (DMEM/F12; Invitrogen) supplemented with 10mmol/l L-glutamine, 100U/ml penicillin, 100µg/ml streptomycin, 20% fetal bovine serum (FBS, Invitrogen) and endothelial cell growth supplement (ECGS, Becton-Dickinson Biosciences) at 37°C and 5% CO 2 . HUVEC between P3 and P4 were used for all experiments. The collagen gel assay was done based on established protocol. Briefly, wells of a six-well tissue culture plate were coated with 1.5mg/ml of rat tail collagen type 1 and 3µg/ml of fibronectin (Becton-Dickinson Biosciences). HUVECs (5 X 10 5 ) were seeded in each collagen-coated well and allowed to attach for 1 h. A second collagen layer was added to a well and allowed to polymerize. HUVECs were then co-cultured with PLGF-treated macrophages in a transwell. Five random images were taken from each experimental conditions, and analyzed by NIH ImageJ. Number of sprouts per bead was determined, where a sprout is defined as a vessel of length equal to the diameter of a bead. Sprout length was also measured in arbitrary units. For statistical analysis, 25 beads were assessed for each condition. Zhang 
Results
Isolation and differentiation of mouse bone-marrow-derived macrophages
First, we isolated mouse bone-marrow cells and then purified macrophages (BM-MΦ) based on F4/80 expression by flow cytometry (Fig. 1A) . The purified BM-MΦ were then kept in culture (Fig. 1B) .
PLGF dose-dependently polarizes BM-MΦ into a M2 subtype
Then we treated cultured BM-MΦ with different doses (low dose: 1nmol/l; medium dose: 5nmol/l; high dose: 25nmol/l) of PLGF ( Fig. 2A) . We examined whether PLGF may alter the viability of BM-MΦ in an MTT assay. We found that PLGF did not change the cell number of cultured BM-MΦ 4 days after PLGF treatment (Fig. 2B) . Then, we examined whether PLGF may alter macrophage polarization by flow cytometry using a M2-macrophage-specific marker CD206. We found that PLGF dose-dependently polarized BM-MΦ into a M2 subtype, by representative flow charts (Fig. 2C) , and by quantification (Fig. 2D) . These data suggest that PLGF dose-dependently polarizes BM-MΦ into a M2 subtype.
M2 macrophages produce high levels of PLGF
We has shown that PLGF promotes neovascularization in MSCs-mediated cardiac muscle repair [23] . Thus, we aimed to find out whether macrophage polarization may change its PLGF production. We purified M1 and M2 macrophage based on expression of CD206 by flow cytometry. Then we analyzed gene expression in M1 and M2 subpopulations, after confirmation of the purity of M1 and M2 macrophages based on the transcript level of a M1 marker iNOS and a M2 marker Arginase (Fig. 3A) . While we did not find any changes in these genes in the M1 or M2 macrophages, we found that M2 macrophages expressed significantly higher PLGF transcripts (Fig. 3A) and secreted significantly more PLGF (Fig. 3B ), compared to M1 macrophages. These data suggest that M2 macrophages produce high PLGF, and may contribute to the MSCs-mediated cardiac muscle repair.
PLGF-polarized M2 macrophages promote neovascularization in vitro
In order to confirm that PLGF-polarized M2 macrophages may promote neovascularization, we applied a collagen gel assay using HUVEC, in which HUVEC cells were cultured in a transwell with the identical number of macrophages polarized by different doses of PLGF (Fig. 4A ). In this model, macrophages were first treated with different doses of PLGF to induce M2 polarization, and then the cultured media were removed to avoid the effects of the exogenous PLGF on HUVECs. Afterwards, the polarized macrophages were cocultured in a transwell with HUVECs at a ratio of 1:1. After 7 days, the tubular structures was quantified (Fig. 4A) .
First, M2 macrophage polarization was examined by flow cytometry, showing that macrophages that were treated with higher doses of PLGF contained more M2 subtype (Fig. 4B) . Then, we found that M2 macrophages significantly increased tubular structure formation in HUVEC cells in the collagen gel assay, by representative images (Fig. 4C) , and by 
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In this model, first, macrophages were treated with different doses of PLGF to induce M2 polarization, and then the cultured media were removed to avoid the effects of the exogenous PLGF on HUVECs. Afterwards, the polarized macrophages were co-cultured with HUVECs in a transwell and the tubular structure formation was examined after 7 days. (B) M2 macrophage polarization was confirmed by flow cytometry, shown by quantification. (C-D) HUVEC tubular structure formation by M2-polarized macrophages was evaluated and shown by representative images (C), and by quantification (D). *p<0.05. NS: non-significant. N=5. Scale bar is 30µm. (Fig. 4D) . Together, these data suggest that PLGF-polarized M2 macrophages promote neovascularization in vitro. Based on our findings in the current study and our previous work [23] , we propose a model in which MSCs-derived PLGF may induce macrophage polarization into a M2 subpopulation, which in turn releases more PLGF to promote local neovascularization to enhance post-injury cardiac muscle repair (Fig. 5 ).
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Discussion
Transplantation of MSCs has established therapeutic effects on cardiac muscle repair after injury. However, previous studies have shown some controversial results. Moreover, the studies on the underlying mechanisms are ill-defined [3] [4] [5] 25] . Hence, we have recently studied this question, using both in vivo and in vitro models.
In our previous work, we isolated and cultured primary mouse MSCs, and assured the phenotypes of MSCs using classical differentiation assays. In order to evaluate the effects of MSCs transplantation on the recovery and regeneration of the injured mouse heart, we transplanted MSCs immediately after induction of acute myocardial infarction, which significantly improved cardiac muscle repair and heart function. We further show that the direct contribution of MSCs to regenerated cardiac muscle cells is very limited, and MSCs appear to promote neovascularization through secreting PLGF, but not VEGF-A. These data are consistent with an essential role of PLGF in pathological vascularization [26] , and highlights PLGF as a key factor during cardiac muscle repair. However, the number of MSCs detected in the injured mouse heart is very modest. Therefore, the PLGF from MSCs may not be the major source of PLGF in the injured heart, and may be just an initiator for PLGF production. Hence, we hypothesize that MSCs may interact with macrophages to mediate the effects on neovascularization.
In this study, we tried to prove this hypothesis. First, we isolated bone-marrow cells from mice and then purified macrophages (BM-MΦ) from bone-marrow derived cells. We found that PLGF did not change the cell number of macrophages 4 days after PLGF treatment. These data suggest that PLGF may not alter macrophage apoptosis or proliferation. Hence, it is expected that PLGF may change the polarization of macrophages. Indeed, we found that PLGF dose-dependently polarized BM-MΦ into a M2 subtype, and most interestingly, M2 macrophages produced about 50 times more PLGF than M1 macrophages. These data suggest that transplanted MSCs may secrete PLGF to polarize macrophages, which subsequently secrete more PLGF.
To confirm a role of M2 macrophages in neovascularization, we used a collagen gel assay, in which HUVEC cells were cultured in a transwell with identical number of macrophages polarized by different doses of PLGF. We found that M2 macrophages significantly increased tubular structure formation in HUVEC cells. Together, these data suggest that PLGF-polarized M2 macrophages promote neovascularization in vitro.
Based on our findings in the current study and our previous work [23] , we propose a model in which MSCs-derived PLGF may induce macrophage polarization into a M2 Fig. 5 . Schematic of the model. MSCs-derived PLGF may induce macrophage polarization into a M2 subpopulation, which in turn releases more PLGF to promote local neovascularization to enhance post-injury cardiac muscle repair.
